Rhenman & Partners Asset Management AB »

Apellis Pharmaceuticals shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 178k 58.78
2023-09-30 $17M 190k 91.10
2023-06-30 $17M 190k 91.10
2023-03-31 $12M 185k 66.02
2022-12-31 $10M 200k 51.71
2022-09-30 $13M 220k 60.49
2022-06-30 $9.5M 210k 45.22
2022-03-31 $19M 377k 50.81
2021-12-31 $21M 430k 47.95
2021-09-30 $19M 561k 32.96
2021-06-30 $19M 305k 63.20
2021-03-31 $12M 270k 42.91
2020-12-31 $15M 270k 57.20
2020-09-30 $6.8M 225k 30.17
2020-06-30 $5.4M 165k 32.66
2020-03-31 $2.7M 100k 26.79
2019-12-31 $2.4M 80k 30.62